Low-risk differentiated thyroid carcinoma patients still deserve I-131 remnant ablation after total thyroidectomy

被引：0

作者：

Verburg, F. A. ^{[2
]}

Luster, M. ^{[1
]}

机构：

[1] Univ Ulm, Dept Nucl Med, D-89081 Ulm, Germany

[2] Univ Wurzburg, Dept Nucl Med, Wurzburg, Germany

来源：

MINERVA CHIRURGICA | 2010年 / 65卷 / 01期

关键词：

Thyroid neoplasms; Thyroidectomy; Risk factors; LOW-IODINE DIET; RADIOIODINE THERAPY; PAPILLARY; CANCER; IMPACT; GUIDELINES; RATES;

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

After total thyroidectomy for differentiated thyroid carcinoma (DTC), I-131 ablation is usually recommended in all patients but those classified as "very low risk", and mandatory for all patients classified as "high risk". For those classified as "low risk" there is some discussion as to whether I-131 ablation should still be performed. In this review various staging systems for classifying patients as "very low risk" "low risk" or "high risk" are discussed, followed by an overview of why I-131 ablation remains an eminently sensible idea in "low risk" patients.

引用

页码：95 / 100

页数：6

共 50 条

[1] FACTORS AFFECTING I-131 ABLATION OF THYROID REMNANT AFTER THYROIDECTOMY FOR DIFFERENTIATED THYROID-CANCER
CECCARELLI, C
MARTINO, E
LIPPI, F
GIANCHECCHI, D
LUCHETTI, F
BRACCI, E
PINCHERA, A
[J]. JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1987, 31 (01): : 46 - 46
[2] Thyroid remnant ablation of differentiated thyroid carcinoma: a comparison of ablation success with high and low doses of radioiodine (I-131)
Elrasad, S. A. A.
Abdelhafeez, Y.
Husseini, M. A.
Amin, R. A. A.
Elrefaei, S.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S328 - S328
[3] Effectiveness of Reduced Radioiodine Activity for Thyroid Remnant Ablation after Total Thyroidectomy in Patients with Low to Intermediate Risk Differentiated Thyroid Carcinoma
Todica, Andrei
Haidvogl, Sabine
Fendler, Wolfgang Peter
Ilhan, Harun
Rominger, Axel
Haug, Alexander Robert
Bartenstein, Peter
Lehner, Sebastian
[J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2017, 56 (06): : 211 - 218
[4] Predicting factors of successful postsurgical remnant ablation with I-131 in patients with differentiated thyroid carcinoma
Fallahi, B.
Beiki, D.
Takavar, A.
Eftekhari, M.
Fard-Esfahani, A.
Gilani, K. Ansari
Saghari, M.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S320 - S320
[5] Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma
Kim, TY
Kim, WB
Kim, ES
Ryu, JS
Yeo, JS
Kim, SC
Hong, SJ
Shong, YK
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03): : 1440 - 1445
[6] Rate of thyroglossal duct remnant visualization after total thyroidectomy for differentiated thyroid carcinoma and its impact on clinical outcome of radioactive iodine (I-131) ablation
Sayed, Mohamed Hosny Mohamed
Farghaly, Hussein Rabie Saleh
Fadl, Fahd Ahmad
[J]. INDIAN JOURNAL OF NUCLEAR MEDICINE, 2015, 30 (02): : 116 - 121
[7] I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
Lin, Rong
Banafea, Omar
Ye, Jin
[J]. BMC GASTROENTEROLOGY, 2015, 15
[8] I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
Rong Lin
Omar Banafea
Jin Ye
[J]. BMC Gastroenterology, 15
[9] I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence
Yan Shengguang
Ji-Eun, Choi
He Lijuan
[J]. MEDICAL SCIENCE MONITOR, 2016, 22 : 2439 - 2450
[10] Efficacy of Low-Dose I-131 Therapy for the Postoperative Ablation of Low-Risk Differentiated Thyroid Cancer Patients
Caglar, M.
Bozkurt, F.
Kapulu, C.
Ugur, O.
Bayraktar, M.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S344 - S344

← 1 2 3 4 5 →